GlobeNewswire Inc.··Researchandmarkets.ComBiopharma Logistics Set to Nearly Triple, Reaching $384B by 2032
Biopharmaceutical third-party logistics market expected to surge from $140B (2025) to $384B (2032), driven by complex biologics, regulatory demands, and cold-chain technology innovation.
CAHTMOFDXUPSMCK+1supply chainregulatory compliance